Serial Number | 97639433 |
Word Mark | VAULT BIOVENTURES |
Filing Date | Wednesday, October 19, 2022 |
Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
Status Date | Thursday, November 7, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Pharmaceutical products for the treatment of viral and infectious diseases, allergies, diabetes; and, for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood, weight, pregnancy and immune system related diseases and disorders, all for the purpose of integrating digital and biopharmaceutical therapeutics to increase health-span and life-span for all humanity |
NOT AVAILABLE | "BIOVENTURES" |
Goods and Services | Pharmaceutical product development services; Pharmaceutical research services |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, November 3, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, November 3, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Vault Bioventures, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92130 |
Event Date | Event Description |
Saturday, October 22, 2022 | NEW APPLICATION ENTERED |
Thursday, November 3, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, June 27, 2023 | ASSIGNED TO EXAMINER |
Wednesday, June 28, 2023 | NON-FINAL ACTION WRITTEN |
Wednesday, June 28, 2023 | NON-FINAL ACTION E-MAILED |
Wednesday, June 28, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, September 26, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Tuesday, September 26, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Thursday, December 28, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, December 28, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, December 29, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, January 30, 2024 | FINAL REFUSAL WRITTEN |
Tuesday, January 30, 2024 | FINAL REFUSAL E-MAILED |
Tuesday, January 30, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Monday, February 5, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, February 5, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Monday, February 5, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Monday, February 5, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Monday, April 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, April 29, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Tuesday, April 30, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, May 3, 2024 | LETTER OF SUSPENSION E-MAILED |
Friday, May 3, 2024 | SUSPENSION LETTER WRITTEN |
Friday, May 3, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Friday, August 16, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Thursday, November 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, November 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, November 7, 2024 | ASSIGNED TO LIE |